Fig. 9From: Emodin-loaded polymer-lipid hybrid nanoparticles enhance the sensitivity of breast cancer to doxorubicin by inhibiting epithelial–mesenchymal transitionE-PLNs enhance the sensitivity of breast cancer to doxorubicin by inhibiting epithelial–mesenchymal transitionBack to article page